KIMBERLY CLARK CORP
For the period ended Dec 31, 2023. Filed Feb 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
As of December 31, 2023, we own or lease:
our principal executive office located in the Dallas, Texas metropolitan area;
five operating segment and geographic headquarters at three U.S. and two international locations; and
four global business service centers at one U.S. and three international locations.
The locations of our and our equity affiliates' principal production facilities by major geographic areas of the world are as follows:
| Geographic Area: | Number ofFacilities |
|---|---|
| North America (in 14 states in the U.S.) | 28 |
| Outside North America | 54 |
| Total (in 33 countries) | 82 |
Many of these facilities produce multiple products, some across multiple segments. Consumer tissue and K-C Professional products are produced in 47 facilities and personal care products are produced in 48 facilities. We believe that our and our equity affiliates' facilities are suitable for their purpose, adequate to support their businesses and well maintained.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.